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Abstract Ionizing radiation alone or in combination with
chemotherapy is the main treatment modality for brain
tumors including glioblastoma. Adult neurons and astro-
cytes demonstrate substantial radioresistance; in contrast,
human neural stem cells (NSC) are highly sensitive to
radiation via induction of apoptosis. Irradiation of tumor
cells has the potential risk of affecting the viability and
function of NSC. In this study, we have evaluated the effects
of irradiated glioblastoma cells on viability, proliferation
and differentiation potential of non-irradiated (bystander)
NSC through radiation-induced signaling cascades. Using
media transfer experiments, we demonstrated significant
effects of the U87MG glioblastoma secretome after gamma-
irradiation on apoptosis in non-irradiated NSC. Addition of
anti-TRAIL antibody to the transferred media partially
suppressed apoptosis in NSC. Furthermore, we observed a
dramatic increase in the production and secretion of IL8,
TGFb1 and IL6 by irradiated glioblastoma cells, which
could promote glioblastoma cell survival and modify the
effects of death factors in bystander NSC. While differen-
tiation of NSC into neurons and astrocytes occurred effi-
ciently with the corresponding differentiation media,
pretreatment of NSC for 8 h with medium from irradiated
glioblastoma cells selectively suppressed the differentiation
of NSC into neurons, but not into astrocytes. Exogenous IL8
and TGFb1 increased NSC/NPC survival, but also
suppressed neuronal differentiation. On the other hand, IL6
was known to positively affect survival and differentiation of
astrocyte progenitors. We established a U87MG neuro-
sphere culture that was substantially enriched by SOX2? and
CD133? glioma stem-like cells (GSC). Gamma-irradiation
up-regulated apoptotic death in GSC via the FasL/Fas
pathway.Media transfer experiments from irradiatedGSC to
non-targeted NSC again demonstrated induction of apopto-
sis and suppression of neuronal differentiation of NSC. In
summary, intercellular communication between glioblas-
toma cells and bystander NSC/NPC could be involved in the
amplification of cancer pathology in the brain.
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CHX Cycloheximide
DR5 Death recepotor-5 (synonym for TRAIL-R2)
FACS Fluorescence-activated cell sorter
FasL Fas ligand
FGF2 Fibroblast growth factor-2 (basic)
GB Glioblastoma
GSC Glioma stem-like cells
IjB Inhibitor of NF-jB
IKK Inhibitor nuclear factor kappa B kinase
JNK c-Jun N-terminal kinase
MAPK Mitogen-activated protein kinase
MEK MAPK/ERK kinase
MEF Median fluorescence intensity
NF-jB Nuclear factor kappa B
NPC Neural progenitor cells
NSC Neural stem cells
PARP1 Poly (ADP-ribose) polymerase-1
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STAT Signal transducers and activators of
transcription
TGFb Transforming growth factor beta
TGFb-R TGFb-receptor
TNFa Tumor necrosis factor alpha
TRAIL TNF-related apoptosis ligand
TRAIL-R2 TRAIL-receptor-2
Introduction
Glioblastoma is the most common primary malignant brain
tumor affecting more than 10,000 new patients in the US
each year. Despite advances in radiation therapy and che-
motherapy, outcomes remain really poor with a median
survival rate of 12–15 months [1]. Detailed investigations
of the somatic genomic landscape of glioblastoma using
numerous human glioblastoma samples and established
cancer lines demonstrated a connection between gene
alteration and signaling pathway modifications in glio-
blastoma cells, which include RTK pathways (EGFR1,
FGFR2 or PDGFRA), PI3K/PTEN-AKT pathway, MAPK
pathways (together with NF1 and BRAF), p53 pathway
(together with MDM2, MDM4) and RB1 pathway (RB1,
CDK4 and CDK6) [2, 3]. A role for the IKK-NF-jB
pathway via activating mutations was additionally high-
lighted in some types of glioblastoma [4].
U87MG is a commonly studied grade IV glioblastoma
cell line that has been analyzed in numerous studies over
many years. The mutational landscape of the U87MG gen-
ome is extremely complicated. Protein coding sequences of
genes were disrupted predominantly in this cancer cell line
due to small insertions and deletions, large deletions, and
translocations. In total, 512 genes were homozygously
mutated, including 154 by single nucleotide variation, 178
by small insertions and deletions, 145 by large microdele-
tions, and 35 by interchromosomal translocations to reveal a
highly mutated cell line genome [5]. Among these changes
known homozygous mutations inPTEN and TP53, as well as
EGFR amplification were identified.
Ionizing radiation alone or in combination with chemo-
therapy is the main treatment procedure for glioblastoma.
Normal adult neurons and glial cells, which are terminally
differentiated cells, exhibit a substantial radioresistance. In
contrast, neural stem and progenitor cells (NSC/NPC) hav-
ing significant proliferative capacities are highly sensitive to
ionizing radiation. Numerous clinical observations and
experiments with animals demonstrated that cranial irradi-
ation used for treatment of brain tumors may cause sub-
stantial cognitive deficits such as impairing learning,
attention and memory, due to inhibition of the proliferation
and death of neural stem cells [2, 6–12]. Ionizing irradiation
causes DNA damage via generation of reactive oxygen
species (ROS) that further affect numerous cell signaling
pathways and the corresponding gene expression followed
by inhibition of cell proliferation, induction of the DNA
repair mechanisms and, finally, either cell survival (that is
achieved using multiple mechanisms, including protective
autophagy) or cell death (via apoptosis, necrosis and
destructive autophagy) [13, 14]. Directly irradiated cells,
dramatically change the regulation of gene expression by
induction of survival programs, including induction of gene
expression of numerous cytokines, growth factors directed
by activation of the transcription factors NF-jB, STAT3,
AP1 and several others. This is a common feature of stress
response and, furthermore, a basis for the induction of a
bystander response (which might include apoptosis and
genomic instability as endpoints) in non-targeted cells [15,
16]. The tumor microenvironment actively regulates cell
signaling pathways and gene expression in cancer cells [17].
On the other hand, radiation-induced signals from treated
tumors to non-irradiated bystander cells [18, 19], could be
modulated by tumor microenvironment. Numerous investi-
gations of the radiation-induced bystander response of non-
targeted cells during the last two decades have dramatically
changed the paradigm of radiobiology concerning general
regulation of radiation response [18–20].
In spite of great importance of neural stem cells (NSC)
in the development and maintenance of the nervous system,
molecular mechanisms of the radiation-induced bystander
effects in NSC remain mostly unknown. In the present
study we investigate radiation-induced signaling in directly
targeted human glioblastoma cells and NSC, as well as the
subsequent induction of intercellular crosstalk between
irradiated glioblastoma cells and non-targeted (bystander)
NSC that could ultimately affect apoptosis, survival, pro-
liferation and differentiation of non-targeted NSC.
Results
Cell signaling pathways in human neural stem cells
(NSC) and U87MG glioblastoma cells
before and after c-irradiation
Human SOX2?, Nestin? neural stem cells (NSC) (Fig. 1)
and U87MG human glioblastoma cells (Fig. 1c–f) were
either non-irradiated or exposed to graded doses of c-
irradiation (2.5–10 Gy). In a close correlation with previ-
ously published data [3, 4], constitutive activation of AKT
(due to EGFR amplification and PTEN deficiency) and
IKK-NF-jB, but a strong down-regulation of p53 levels
were determined in non-treated U87MG glioblastoma cells.
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In contrast, substantially lower levels of the active (phos-
phorylated) AKT and NF-jB p65 were revealed in normal
human NSC (Fig. 1c, d). However, active phosphorylated
forms of ERK1/2 and MAPK p38 were permanently
present in both NSC and U87MG cells. Irradiation mark-
edly up-regulated the levels of active NF-jB p65-P(S536)
in NSC, but gradually decreased its high basal levels in
glioblastoma cells. c-Irradiation further up-regulated
phospho-ERK(T202/Y204) levels in NSC, while these
levels were relatively stable in irradiated U87MG cells 3 h
after treatment. Changes in the levels of phospho-JNK had
the opposite trends in NSC and U87MG cells after
irradiation (Fig. 1c). c-Irradiation strongly increased p53
protein levels in dose-depended manner in NSC, while only
the trace amount of p53 were detected in glioblastoma cells
(Fig. 1d). BAX protein expression level (controlled by
transcription factor p53) was also dramatically down-reg-
ulated in glioblastoma cells, compared to NSC, resulting in
a general suppression of the p53-BAX-dependent apoptotic
signaling in glioblastoma cells (Fig. 1d).
Early induction of radiation-induced apoptotic pathway
reflected by caspase-3-mediated cleavage of PARP-1 was
observed in human NSC [12], but not in irradiated glio-
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Fig. 1 Effects of c-radiation on signaling pathways and survival of
NSCs and human U87MG glioblastoma cells. a Immunostaining of
NSC using polyclonal antibody to SOX2 (a pluripotency marker) and
monoclonal antibody to Nestin (early neuroprogenitor marker).
Bar = 50 lm. b Immunostaining COX2 expression in NSC before
and 3 h after irradiation. c, d Western blot analysis of expression of
the indicated proteins in human NSC and U87MG cells was
performed 3 h after treatment by increasing doses of c-irradiation.
A ratio of active phosphorylated form to total level of signaling
protein is indicated. For TRAIL and p53, normalization was based on
beta-actin levels. e, f Effect of c-irradiation on survival of human
NSC and U87MG cells. Numbers of live cells attached to fibronectin
matrix were determined before irradiation at time point 0 and 48 h
after treatment. Immunostaining SOX2 in NSC was then performed.
Bar = 50 lm. The number of U87MG cells was detected using a
phase contrast microscopy. Relative cell survival (normalized to
initial cell density at time point 0) is indicated. Pooled results of four
independent experiments are shown in f. Error bars represent
means ? SD (p\ 0.05, Student’s t test); star indicates a significant
difference. A typical result is shown in e
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had quite similar levels of the anti-apoptotic survivin (data
not shown) and cFLIP (Fig. 1d) suggesting that these
proteins were not critically responsible for a sharp differ-
ence in the induction of apoptosis in two cell lines.
Changes in the COX2 protein level (two bands, non-gly-
cosylated p58 and glycosylated p72 protein subunit), a
classical NF-jB target, showed opposite trends in NSC and
U87MG cells after irradiation: a strong up-regulation in
NSC and down-regulation of basal levels in U87MG cells
3 h after treatment (Fig. 1d). Interestingly, non-irradiated
NSC contained low basal levels of COX2 protein with
predominantly nuclear localization, while after irradiation
cytoplasmic COX2 levels dramatically increased in NSC
(Fig. 1b). In contrast, high basal levels of COX2 with
cytoplasmic localization before and after treatment were
observed in many human glioblastomas, including U87MG
[21]. Furthermore, high protein levels of the endogenous
TGFb1 and modest levels of TGFb-R2 were detected in
glioblastoma cells after irradiation. Radiation-induced
upregulation of TGFb1 and TGFbR2 gene expression and a
radioprotective role for TGFb1-induced signaling path-
ways are known as characteristic features of many types of
cancer, including glioblastoma [22]. The opposite trend of
the permanent upregulation of TGFb-R2 levels was char-
acteristic for NSC (Fig. 1d) highlighting a higher sensi-
tivity of irradiated NSC to TGFb-R mediated signaling
with the exogenous TGFb. Endogenous production of
death ligand TRAIL at moderate levels was detected in
both cell lines (Fig. 1d). As early as 48 h after irradiation, a
general survival of NSC was substantially decreased, while
only modest changes in survival were observed among
U87MG cells based on number of matrix-attached cells and
Trypan blue exclusion test for floating cells (Fig. 1e, f).
Effects of small molecule inhibitors of cell signaling
pathways on radiation-induced apoptosis and survival
of U87MG cells
To further evaluate a role of cell signaling pathways for
pro-apoptotic sensitization of glioblastoma cells, small
molecule inhibitors specific for several pathways were used
either alone or in combination with radiation (Fig. 2).
Optimal doses for the various inhibitors (including inhibi-
tion of AKT-S473 and IKK-S176/180) employed in this
study were chosen carefully on the basis of an earlier study
in NSC [23]. Figure 2a demonstrates the data on the
specificity of small molecule inhibitors in U87MG cells
obtained with inhibitors alone or in combination with
irradiation. LY294002 (50 lM) by inhibiting PI3K-AKT in
non-irradiated and irradiated cells substantially up-regu-
lated radiation-induced apoptosis of U87MG cells 48 h
after treatment (Fig. 2b). BMS345541 significantly
blocked IKK-NF-jB in non-irradiated cells, but was less
effective in irradiated glioblastoma cells. Correspondingly,
it had only a modest, but statistically significant effect on
the increase of radiation-induced apoptosis (Fig. 2b and
data nit shown). All other inhibitors used were not efficient
for rapid up-regulation of apoptosis (Fig. 2b). For example,
U0121, a MEK-ERK inhibitor (Fig. 2a, the bottom panel)
increased the percentage cells at G1 phase, without up-
regulating apoptosis (Fig. 2b). Inhibition of ATM-kinase
by KU55933 (20 lM) or STAT3-dimerization by STAT-
inhibitor-6 (50 lM) resulted in the enrichment of cells at
G2/M phase without notable up-regulation of apoptosis
(Fig. 2c). In contrast, a combination of LY294002 (50 lM)
with BMS345541 (10 lM) was very effective for an
extensive apoptosis induction involving a large fraction of
cells. However, c-irradiation did not further increase pro-
apoptotic effects of this treatment (Fig. 2b). Cleavage and
activation of caspase-3 (an additional proof of apoptotic
commitment) were observed after treatment with
BMS345541, an IKK-NF-jB inhibitor, LY294002, a PI3K-
AKT inhibitor, alone or in combination, before and after
irradiation (Fig. 2a).
High levels of total (relatively slow, non-apoptotic)
death of G2/M-arrested glioblastoma cells were detected
only 10-12 days after irradiation at 10 Gy, using clono-
genic survival assay (Fig. 2d). Combined treatment by c-
radiation and LY294002 (50 lM), further decreased clo-
nogenic survival of glioblastoma cells, as well as increased
levels of cell death (Fig. 2b, c). Surprisingly, a strong
effect of up-regulation of total cell death was achieved
after treatment of U87MG cells with BMS345541 (10 lM)
(Fig. 2d). Interestingly, BMS345541 alone or in a combi-
nation with irradiation induced only low to moderate levels
of apoptosis, while it almost completely killed cancer cell
population, probably, via non-apoptotic mechanisms
12 days after treatment (Fig. 2d). ATM-kinase- and
STAT3- inhibitors also further decreased clonogenic sur-
vival after c-irradiation (Fig. 2d). Based on the results of
the induction of apoptosis and clonogenic survival data,
combined treatment of glioblastoma cells by PI3K-AKT
and IKK-NF-jB inhibitors might have a therapeutic sig-
nificance. The main problem, however, is a certain sensi-
tivity of human NSC to the above mentioned treatment
[23].
Radiation-induced changes in glioblastoma secretome
and in surface expression of death receptors and their
ligands
Since IKK-NF-jB is one the critical pathways that regulate
glioblastoma survival, the expression levels of some of the
well-known downstream targets of IKK-NF-jB pathway,
IL8, IL6 and TRAIL [24], as well as TGFb1, which could
serve as a upstream regulator for NF-jB activation [25],
Apoptosis (2014) 19:1736–1754 1739
123
Author's personal copy
were examined in glioblastoma cells. Non-irradiated
U87MG cells secreted high basal levels of IL8, IL6 and
TGFb1 into the culture media. BMS345541, an inhibitor of
IKK-NF-jB, substantially reduced the basal secretion of
IL6 and IL8 (Suppl. Figure 1A and B). In line with earlier
studies [22, 26], our experiments demonstrated radiation-
induced up-regulation of production and secretion of
TGFb1, IL8 and IL6 by U87MG cells. Interestingly, NF-
jB suppression by BMS345541 was less pronounced in
irradiated glioblastoma cells, compared to non-irradiated
cells, in concert with highly stable ERK- and AKT activ-
ities (Fig. 2a), correlating with incomplete suppression of
IL6 and IL8 secretion by inhibitor in irradiated cells
(Suppl. Figure 1A and B). Levels of soluble TRAIL were
very low in conditioned media but significantly increased
after irradiation (10 Gy) of glioblastoma cells (Suppl.
Figure 1D).
Irradiation additionally increased Fas expression on the
cell surface; practically, the whole population of U87MG
cells became Fas positive after treatment with 10 Gy of c-
rays (Suppl. Figure 2A). In contrast, only 50 % of U87MG
cell population was positive for TRAIL-R2/DR5 surface
expression in these conditions; no TRAIL-R1/DR4 surface
expression was detected. A modest increase in surface
expression of the membrane forms of FasL and TRAIL was
detected after irradiation (Suppl. Figure 2A). Increased
TRAIL production in irradiated U87MG cells was also
confirmed by Western blotting (see Fig. 1d).
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Fig. 2 Effects of small molecule inhibitors on cell cycle, apoptosis
and survival of U87MG cells. a Specificity of inhibitors LY294002
(PI3K-AKT; 50 lM), BMS345541 (IKK-NF-jB; 10 lM) and U0121
(MEK-ERK, 10 lM) in U87MG cells. Western blot analysis of
indicated proteins was performed in non-irradiated and irradiated
glioblastoma cells in the absence or in the presence of small molecule
inhibitors. A ratio of active phosphorylated form to total level of
signaling protein is indicated. b, c U87MG cells were c-irradiated
(10 Gy) in the presence or in the absence of small molecule
inhibitors: LY294002 (PI3K-AKT; 50 lM), U0126 (MEK-ERK;
10 lM), BMS345541 (IKK-NF-jB; 10 lM); KU55933 (ATM-
kinase; 10 lM) and STAT3-inhibiror-6 (50 lM). Cell cycle-apoptosis
analysis was performed 48 h after treatment. d Clonogenic survival
assay was performed for control or irradiated cells in the absence or in
the presence of indicated inhibitors (i). Pooled results of three
independent experiments are shown. Error bars represent
means ? SD (p\ 0.05)
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Our previous results demonstrated that NSC were very
sensitive to treatment with the exogenous TRAIL, and
radiation-induced apoptosis of NSC was mediated by the
endogenous TRAIL [12]. In contrast, U87MG cells were
resistant to endogenous or exogenous TRAIL alone.
However, TRAIL in combination with CHX dramatically
increased apoptosis and total death in U87MG cells (Suppl.
Figure 2B and C). On the other hand, U87MG responded to
treatment by the exogenous FasL (40 ng/ml) inducing
apoptosis that was further increased in the presence of
CHX (2 lg/ml) (Suppl. Figure 2B). Clonogenic survival
assay confirmed an almost 100 % death rate of
glioblastoma cells after combined treatment of FasL and
CHX or after treatment with TRAIL and CHX (Suppl.
Figure 2C). Furthermore, c-irradiation up-regulated levels
of both apoptotic and total death of FasL-pretreated
U87MG cells (Suppl. Figure 2B and C).
Effects of the exogenous TGFb, IL8, IL6 and TRAIL
on viability and neuronal differentiation of NSC
Abundant expression of cytokines and growth factors by
glioblastoma cells, especially after irradiation, provoked an
intriguing question regarding their potential role in
Fig. 3 Cell cycle and neuronal differentiation of NSC: effects of
cytokines and TGFb1. a Effects of growth factor/cytokines on the cell
cycle-apoptosis of control and irradiated NSC. Recombinant TGFb1
(20 ng/ml), IL6 (50 ng/ml) and IL8 (50 ng/ml) alone or in combi-
nation were added to serum-free NSC media. Cell cycle-apoptosis
analysis was performed using PI staining and FACS analysis 48 h
after culture initiation. Results of a typical experiment (one from four)
are shown. b, c, d Neuronal differentiation of NSC was initiated by
serum-free differentiation media in the presence or in the absence of
TRAIL (50 mg/ml), IL6 (50 ng/ml) or TRAIL ? IL6. After 10 days
of growth cells were fixed and used for immunostaining. Confocal
analysis of immunofluorescent images was performed using mono-
clonal Ab against an early neuroprogenitor marker, Nestin (red), and
polyclonal Ab against a neuronal marker, Doublecortin (green).
Bar = 50 lm. Typical images are shown in b. A ratio of the number
of green cells to the number of red cells and relative cell survival
10 days after initiation of differentiation were determined. Pooled
results of three independent experiments are shown in c, d. Error bars
represent means ± SD (p\ 0.05, Student’s t test); star indicates a
significant difference. e Effects of TRAIL (50 ng/ml), CHX (1 lg/
ml), and TRAIL ? CHX on induction of apoptosis in NSC 24 h after
treatment
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intercellular communication between glioblastoma cells
and NSC, which produced only the trace endogenous levels
of these cytokines. Using the individual recombinant pro-
teins, well-pronounced protective effects of TGFb1 (20 ng/
ml), IL6 (50 ng/ml) and IL8 (50 ng/ml) either alone or in
combination were observed against radiation-induced
apoptosis of NSC (Fig. 3a). We used higher concentrations
of exogenous cytokines compared to the corresponding
endogenous levels in glioblastoma media after irradiation
(see Suppl. Figure 1), because protein stability of recom-
binant non-glycosylated cytokines, which were also used
without protective structures, such as exosomes or specific
binding proteins, in the culture media was substantially
lower than for the corresponding endogenously produced
cytokines. Interestingly, TGFb1 alone substantially
increased % NSC at G1 phase, reflecting its inhibitory
effects on NSC proliferation [27]. However, a combination
of TGFb1 (20 ng/ml) and irradiation (5-10 Gy) demon-
strated a dramatic increase in survival of irradiated NSC
(Fig. 3a). Of note, is that the lower levels of TGFb1
(1-5 ng/ml) did not exhibit protective anti-apoptotic effects
in irradiated NSC [12]. PGE2, the main signaling molecule
downstream of COX2, also induced a modest pro-apoptotic
effect for irradiated NSC in this range of concentrations
(1–5 ng/ml) (data not shown).
The question arose regarding probable interactions of
pro-apoptotic and pro-survival factors during differentia-
tion of NSC/NPC. Neuronal differentiation of human NSC
was induced by the corresponding serum-free differentia-
tion medium without FGF2 and EGF (Fig. 3b–d). During
this differentiation process high level of precursor cell
death was observed. The gradual progression from cells
positive for neural stem/progenitor cell specific marker
Nestin (red) to cells positive for neuron specific marker
Doublecortin (green) was evident in differentiating cells
(Fig. 3b). Green/red ratio (a ratio of the number of Dou-
blecortin-positive green cells to the number of Nestin-
positive red cells) reflected the degree of neuronal differ-
entiation (Fig. 3d). Relative cell survival of control or
treated cells was determined by manual counting of cells
that were attached to the laminin matrix in six microscopic
areas 10 days after initiation of differentiation (Fig. 3c). As
we previously observed, TRAIL (50 ng/ml) strongly
decreased the final survival of NSC/NPC and the yield of
differentiated neurons [12]. IL6 (50 ng/ml) also decreased
the extent of differentiation and cell survival, even signif-
icantly less than TRAIL. The presence of IL6, however,
partially suppressed negative effects of TRAIL on survival
of NSC (Fig. 3b–d). A control experiment confirmed pro-
apoptotic effects of TRAIL alone or in combination with
CHX on the native NSC (Fig. 3e).
In contrast, TGFb and IL8 demonstrated a strong pro-
survival effect for differentiating NSC/NPC with a
significant suppression of the degree of differentiation
(Fig. 4a–c). Furthermore, we and others previously dem-
onstrated [8, 12] that direct c-irradiation before the
induction of differentiation substantially reduced the effi-
ciency of neuronal differentiation by down-regulating the
survival of neural progenitor cells. The presence of TGFb1
(20 ng/m) could partially maintain neuronal differentiation
after irradiation at 5 Gy. Furthermore, TGFb1 still pro-
tected a small subpopulation of neural precursors after
irradiation with 10 Gy (Fig. 4d–f). Surprisingly, cell sur-
vival during astrocyte differentiation of NSC (10 days after
initiation of differentiation) was not notably affected by
irradiation (at 5 Gy), probably reflecting a deficiency of
surface expression of death receptors in astrocyte precur-
sors. The degree of astrocyte differentiation (based on the
number of GFAP-positive cells) was still low in both cases
of non-treated and irradiated cells 10 days after initiation
of differentiation (data not shown).
Intercellular crosstalk between glioblastoma cells
and NSC before and after c-irradiation
As we already observed (Fig. 2b), gamma-irradiation at
10 Gy induced a G2/M irreversible arrest of U87MG cell
proliferation that was not accompanied by notable levels of
cell death even 48–72 h after treatment (see also Fig. 5d).
To detect the non-targeted effects after irradiation of
glioblastoma (GB) cells on naı¨ve NSC, conditioned media
and media from irradiated cultures of U87MG cells (48 h
after irradiation) were transferred to the naı¨ve NSC for
short (4 h) and prolonged (16–24 h) exposure (Fig. 5).
Levels of the main cytokines in conditioned and irradiated
glioblastoma media used for treatment of NSC are shown
on Suppl. Figure 1. Expression changes in IKK-NF-jB
and, especially, ERK activation in NSC (due to high levels
of IL6, IL8 and TGFb1 in GB media) and down-regulation
of JNK activity were revealed by Western blotting 4 h after
treatment. Initial up-regulation of Caspase-3-mediated
cleavage of PARP-1 in NSC, a characteristic feature of
apoptotic commitment, was also detected after irradiated
media transfer (Fig. 5a). Changes in the intracellular
localization and up-regulation COX2 were revealed in
experiments with short exposure (4 h) of NSC to irradiated
glioblastoma media (Fig. 5b).
16 h after treatment with media transferred from GB
cells, increased apoptotic levels were detected among
exposed NSC using Annexin-V-FITC/PI staining of cells,
reflecting a strong up-regulation in levels of the early and late
phases of apoptosis (Fig. 5f). When apoptotic levels
observed in NSC were normalized to the equal number of
glioblastoma cells used in cultures, we revealed an increase
in apoptotic levels after irradiated media transfer, compared
to conditioned media (Fig. 5f; normalized apoptosis levels
1742 Apoptosis (2014) 19:1736–1754
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shown in the brackets). PI-staining of the cell nuclei and
FACS analysis also demonstrated high apoptotic (pre-G1)
levels in NSC after media transfer (Fig. 5g). Control fresh
GB media had some toxic effect for NSC that was relatively
modest for 8–16 h of treatment. There was a good correla-
tion between two methods of detection of apoptotic cells
(Fig. 5f, g). Dilution of transferred GB media by fresh NSC
media (1:1) decreased the apoptotic level, which was found
to be intermediate between NSC treated with medium
without dilution and the fresh medium (data not shown).
Since moderate level of up-regulation of the endogenous
TRAIL production was detected in U87MG after irradiation,
we investigated effects of TRAIL suppression in transferred
glioblastoma culture for NSC cells. Anti-TRAIL inhibitory
antibody (5 lg/ml) in the media did indeed decrease the
level of apoptosis among NSC after media transfer from
glioblastoma cells (Fig. 5g). On the other hand, NSC effi-
ciently responded to control treatment with the exogenous
recombinant TRAIL (40 ng/ml), especially in combination
with CHX (Fig. 3e). It is possible, however, that additional
factor/s could be involved in the induction of NSC apoptosis,
since only partial suppression of apoptosis by anti-TRAIL
Ab (5 lg/ml) was observed (Fig. 5g).
In summary, results of these experiments demonstrated
well pronounced effects of glioblastoma secreted factors on
survival and regulation of apoptosis in bystander NSC/NPC
Neuronal differentiation of directly irradiated NSC (10 days after irradiation)
5 Gy 10 Gy
D
Nestin, early neuroprogenitor marker, (red); Doublecortin, neuronal marker (green)
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Fig. 4 Neuronal differentiation of directly irradiated NSC: effects of
TGFb1. NSC were non-treated or directly c-irradiated at 5–10 Gy in
the presence or in the absence of TGFb1 (20 ng/ml), IL6, IL8 (50 ng/
ml). a–c Neuronal differentiation of non-irradiated NSC in the
absence or in the presence of indicated cytokines was initiated by
differentiation medium. Confocal analysis of immunofluorescent
images was performed using monoclonal Ab against an early
neuroprogenitor marker, Nestin (red), and polyclonal Ab against a
neuronal marker, Doublecortin (green). Bar = 50 lm. A relative cell
survival and a degree of neuronal differentiation (green/red ratio) for
control and irradiated cells 10 days after initiation of differentiation
were determined. Pooled results of three independent experiments are
shown in b, c. Error bars represent means ? SD (p\ 0.05, Student’s
t test); star indicates a significant difference. d–f Neuronal differen-
tiation of non-irradiated and directly irradiated NSC was initiated by
differentiation media in the absence or in the presence of TGFb1
(20 ng/ml). Confocal analysis of immunefluorescent images was
performed using monoclonal Ab against an early neuroprogenitor
marker, Nestin (red), and polyclonal Ab against a neuronal marker,
Doublecortin (green)
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before and, especially, after irradiation of cancer cells.
Interestingly, non-targeted effects of irradiated glioblas-
toma cells on non-irradiated glioblastoma cells for the
induction of death were not detected (data not shown). This
is in a sharp contrast to induction of TRAIL-mediated
death in the population of bystander NSC after media
transfer from directly irradiated NSC [12], highlighting a
relative non-efficiency of TRAIL/TRAIL-R apoptotic
pathway in irradiated glioblastoma cells.
Bystander effects of irradiated media transfer
on neuronal differentiation of NSC
In our opinion, apoptosis as a biological indicator of
radiation-induced bystander response in NSC induced by
media transfer from irradiated glioblastoma cells was
highly convincing. We next determined whether the sig-
naling triggered by irradiated glioblastoma cells affect the
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1.2    1.9    2.4     2.0 ERK-P/ERK     
0.8    0.8    0.7    0.3  JNK-P/JNK     
Fig. 5 Effects of U87MG conditioned and irradiated media transfer
on cell signaling, cell cycle and death in the bystander NSC. a, b 4 h
after media transfer (the NSC-control medium and GB-irradiated
media), western blot analysis of NSC proteins was performed (a) and
COX2 was detected by immunostaining and microscopy (b).
Bar = 50 lm. c–e U87MG cells attached to the matrix (c) were
non-treated or irradiated at 5–10 Gy in six-well plates at cell density
400,000 cells per a well or 200,000 cells per ml of culture medium.
48 h after irradiation, cell cycle—apoptosis analysis of U87MG was
performed using PI staining and FACS analysis (d). Cell growth of
control and irradiated U87MG cells is shown in e (f) 48 h after
treatment, control-1 (NSC serum-free medium), control-2 (fresh
glioblastoma medium), conditioned (non-irradiated) U87MG
glioblastoma (GB) medium and media from irradiated U87MG cells
(at 5 and 10 Gy) were transferred to naive NSC. 16 h after media
transfer, Annexin-V-FITC/PI staining of NSC followed by FACS
assay (f) was performed. Normalized levels of apoptosis (induced by
secreted activity of 200,000 U87MG cells per ml) are shown in
brackets. g The fresh NSC medium, fresh GB medium, conditioned
GB medium and irradiated GB media were transferred to the native
NSC in the presence of non-specific IgG or anti-TRAIL inhibitory
antibody (5 lg/ml) for 24 h. Then cell-cycle apoptosis analysis of PI-
stained nuclei of NSC was performed using FACS assay. Pooled
results of four independent experiments are shown in g. Error bars
represent means ± SD (p\ 0.05, Student’s t test); star indicates a
significant difference
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of this investigation is shown in Suppl. Figure 3. We made
a 8-h pretreatment of the naive NSC using media trans-
ferred from non-irradiated (control) and from directly
irradiated U87MG glioblastoma cell (48 h after treatment)
followed by neural differentiation of NSC that was induced
by defined differentiation media. Media transfer from
irradiated U87MG cells to naive bystander NSC affected
both cell survival and the degree of differentiation deter-
mined as the ratio of green Doublecortin-positive young
neurons among differentiating progenitor cells identified
by Nestin expression (red) (Fig. 6a, b). We should high-
light that 8-h pretreatment of NSC with the fresh GB-media
(mock control) had only non-significant effects on neural
differentiation of NSC, compared to NSC without pre-
treatment. The decline of neuronal differentiation by media
transfer from conditioned and, especially, irradiated glio-
blastoma cultures was convincing for optimal initial NSC
density (Fig. 6a, b). NSC at higher initial density (106 cells/
well), which were pretreated with transferred media,
exhibited stronger suppression of neuronal differentiation,
but higher levels of relative survival (Fig. 6c, d). Increased
survival of NSC/NPC, which were pretreated and initiated
for neuronal differentiation at high initial cell density, was
a quite expectable phenomenon, due to a possible main-
tenance of the endogenous secretion of the pro-survival
factors, including FGF2 and EGF [28].
GB med (5 Gy) GB med (10 Gy) GB med (0 Gy) Pretreated: GB med (fresh)
Neuronal differentiation of NSC, initial cell density 3x105 cells/well
Nestin, early neuroprogenitor marker, (red); Doublecortin, neuronal marker (green)



























































GB med (5 Gy) GB med (10 Gy) GB med (0 Gy) Pretreated: GB med (fresh)
Fig. 6 Neuronal differentiation of NSC after pretreatment (8 h) with
conditioned media or media from irradiated U87MG cells. a, b NSC
at the initial density (3 9 105 cells/well) were used for pretreatment
with transferred media and induction of differentiation. U87MG cells
were non-treated or directly c-irradiated at 5–10 Gy. Naı¨ve NSC was
primed by 8-h incubation with transferred media from non-irradiated
glioblastoma cells (GB-0 Gy) or from irradiated glioblastoma cells
(GB-5 Gy; GB-10 Gy). Fresh GB media was used as a control. Eight
hours after GB media transfer, neuronal differentiation was initiated
by replacement GB media with serum-free differentiation medium.
Confocal analysis of immunofluorescent images was performed using
monoclonal Ab against an early neuroprogenitor marker, Nestin (red),
and polyclonal Ab against a neuronal marker, Doublecortin (green).
Bar = 50 lm. A relative cell survival and a ratio of the number of
green cells to the number of red cells (reflecting neuronal differen-
tiation) 10 days after initiation of differentiation are indicated in b. c,
d NSC at the higher initial cell density (1 9 106 cells/well) were used
for pretreatment with transferred media and induction of differenti-
ation. Pooled results of four independent experiments are shown in b,
d. Error bars represent means ± SD (p\ 0.05, Student’s t test); star
indicates a significant difference
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In contrast, media transfer experiments demonstrated
the absence of negative regulation of progenitor survival
during astrocyte differentiation at 10- and 18-days after
initiation of differentiation (Fig. 7). Furthermore, priming
with irradiated GB media (at 5 Gy, but not at 10 Gy)
actually promoted astrocyte differentiation (Fig. 7, the
bottom panel). Taken together, the results demonstrated the
early and delayed radiation-induced bystander effects of
U87MG glioblastoma cells on NSC/NPS, which were
mediated by soluble factors from cancer cells secreted into
culture media.
Effects of glioblastoma stem-like cells on viability,
apoptosis and differentiation of neural stem cells
Although the precise origin of glioblastoma (GB) cells is
not known, the current hypothesis is that glioma-initiating
cells, which have characteristics of cancer stem-like cells,
might give rise to GB [29]. To directly assess the inter-
cellular communication between glioblastoma stem-like
cells (GSC) and NSC after ionizing irradiation of GSC,
experiments were performed with direct irradiation of GB
subpopulation enriched with GSC and evaluation of the
induction of a bystander response in non-targeted NSC.
A U87MG neurosphere population enriched by GSC was
established after 15–20 passages of U87MG cells in the
serum-free NSC medium with EGF and FGF2 (Fig. 8a–d),
as previously described [30]. Immunostaining demon-
strated that the vast majority of neurospheres after 20
passages were GFAP?, SOX2? and CD133? (Fig. 8b).
FACS assay further confirmed that approximately 65 % of
cells in neurospheres were CD133?. The percentage of
CD133? cells to some extent dropped 24 h after irradia-
tion, reflecting, probably, a change in CD133 surface
GB - 5 GyGB - 0 Gy
Glial (astrocyte) differentiation of NSC (10 days)
GB - 10 Gy
Nestin, early neuroprogenitor marker, (red); GFAP, astrocyte marker (green)
GB media - fresh
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Fig. 7 Glial differentiation of NSC (10-18 days) after pretreatment
(8 h) with conditioned media or media from irradiated U87MG cells.
Pretreatment of NSC with media from U87MG was performed as
described on Fig. 6. Glial differentiation was induced by astrocyte
differentiation medium. Confocal analysis of immunofluorescent
images was performed using monoclonal Ab against an early
neuroprogenitor marker, Nestin (red), and polyclonal Ab against an
astrocyte marker, GFAP (green). Pooled results of three independent
experiments on cell survival and a degree of astrocyte differentiation
are shown in b. Error bars represent means ± SD (p\ 0.05,
Student’s t test); star indicates a significant difference
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expression on GSC and death of a fraction of CD133? cells
(Fig. 8c). Furthermore, notable fractions of the U87MG
neurosphere population were FAS? or DR5?. Radiation
induced moderate expression of the endogenous membrane
FasL, but did not really affect TRAIL (Fig. 8d). Interest-
ingly, gamma-irradiation of U87MG neurospheres induced
apoptosis that was partially blocked by anti-FasL antibody
(Fig. 8e). On the other hand, addition of the exogenous
recombinant FasL 4 h after irradiation significantly
upregulated (?30 %) apoptosis in GSC, while exogenous
TRAIL exhibited only marginal effects (Fig. 8f). Rela-
tively high basal percentages (35–38 %) of the sub-G1
cells reflected the permanent presence of contaminating
dead cells in the core of non-adherent spheroids during cell
culturing. Taken together, these results highlighted a
notable role of FasL/Fas and a marginal role of TRAIL/
DR5 for radiation-induced apoptosis of U87MG neuro-
spheres. CHX further increased FasL-mediated apoptosis
of neurospheres (Fig. 8g).
Using ELISA, we observed dramatic up-regulation of
TGFb1 and IL8 production 24 h after irradiation of glio-
blastoma neurospheres (Fig. 9a). GSC produced relatively
similar levels of IL8, but substantially higher levels of
TGFb1, especially after irradiation, compared to non-stem
GB cells (see Suppl. Figure 1). A critical role TGFb in
self-renewal of GSC is well established [22, 31]. Media
transfer experiments from non-treated and irradiated
neurospheres to the naı¨ve NSC were performed for
Fig. 8 Establishing of enriched population of glioma stem-like cells
among U87MG neurospheres. a, b U87MG neurosphere culture was
established after 15 passages in serum-free media with EGF and
FGF2. Immunostaining of neurospheres attached to the fibronectin
matrix revealed numerous CD133? and SOX2? U87MG cells.
Furthermore, all cells were GFAP?. Bar = 50 lm. c, d Immunostain-
ing and FACS analysis of U87MG neurosphere culture. Surface
expression levels of CD133, FAS, DR5 and FAS-L were determined
before and 24 h after irradiation (10 Gy). A fraction of CD133?
dropped from 65 to 58 % after irradiation at 10 Gy. e Effects of anti-
FasL Ab on apoptotic levels of U87MG neurospheres before and after
irradiation. Anti-FasL Ab (5 lg/ml) and normal IgG were added to
the media before irradiation. Apoptotic levels were determined 24 h
after irradiation using PI staining and FACS analysis. f Additional
effects of the exogenous FasL and TRAIL (40 ng/ml) on radiation-
induced apoptosis of U87MG neurospheres. Death ligands were
added 4 h after irradiation. g FasL?CHX induced apoptosis of
neurospheres
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evaluation of non-targeted bystander effects. Of note, for
culture of both neurospheres and NSC the same NSC-
media (serum-free, with EGF and FGF2) was used. Media
transfer experiments from neurospheres to the naı¨ve NSC
further demonstrated COX2 induction in NSC (Fig. 9b–d)
and notable up-regulation of NSC apoptosis, especially
after irradiated media transfer. Levels of apoptosis were
detected using Annexin-V-FITC ? PI staining of NSC and
FACS analysis (Fig. 9e). Normalization of apoptotic levels
in NSC was performed to the equal number of glioblastoma
cells used for secretion into the culture media (Fig. 9c, e).
Immunostaining with antibody against cleaved (active)
U87MG neurospheres, 
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Fig. 9 Cytokine secretion, apoptosis and bystander effects in
bystander NSC after media transfer from non-treated and c-irradiated
U87MG neurospheres. a TGFb1 and IL8 secretion before and after
irradiation was determined by ELISA and normalized for 106 U87MG
cells. b–i Media transfer experiments. Control (non-treated) NSC
were stained for Nestin (red) and SOX2 (green) (b). U87MG
neurospheres 24 h after irradiation are shown in c. Up-regulation of
COX2 protein levels in NSC (d) was induced by exposure to media
(4 h) that were transfered from non-irradiated and irradiated U87MG
neurospheres. Apoptosis of NSC (e) was induced by exposure to
media (16 h) that were transfer from non-irradiated and irradiated
(10 Gy) U87MG neurospheres. Apoptosis levels were detected using
Annexin-V-FITC ? PI staining of and FACS analysis. Normalized
levels of apoptosis (induced by secreted activity of 30,000 U87MG
cells) are shown in brackets (e). The left side of f: induction of
Caspase-8 activity in NSC treated by media from irradiated neuro-
spheres. Immunostaining with anti-COX2 (red) and anti-cleaved
fragment of Caspase-8 Abs (green). The right side of the f:
immunostaining and FACS analysis of CD133? NSC. Percentage of
positive cells before and 24 h after media transfer are indicated.
g Apoptosis levels in NSC were detected using PI staining of the NSC
nuclei and the flow cytometry. Media transfer experiments were
performed in the presence of antibodies in transferred media, anti-
TRAIL, anti-FasL (5 lg/ml), or normal IgG as a control. Pooled
results of three independent experiments are shown. Error bars
represent means ? SD (p\ 0.05, Student’s t test); star indicates a
significant difference. h, i U87MG neurospheres were cultured in the
NSC serum-free media. Effects of media transfer from non-treated
(U87MG 0 Gy-M) and irradiated (U87MG 10 Gy-M) neurospheres
with 8-h pretreatment of NSC on the subsequent neuronal differen-
tiation of NSC (10 days). Differentiation of the native NSC in NSC-
media (NSC-M) was used as a reference. Immunostaining for Nestin
and Doublecortin was performed 10 days after initiation of differen-
tiation. Bar = 50 lm. A ratio of green/red cells reflected a degree of
neuronal differentiation
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fragment of caspase-8 further confirmed caspase-8-medi-
ated apoptosis in NSC induced by media from glioblastoma
neurospheres. Apoptosis of NSC was accompanied by a
strong decrease in the fraction of CD133? NSC (Fig. 9f).
Furthermore, apoptosis that was induced by media transfer
to NSC could be significantly blocked by anti-FasL Ab,
and relatively slightly by anti-TRAIL Ab (after irradiation
at 10 Gy) indicating a notable role for FasL and somewhat
a lesser role for TRAIL from GB-transferred media in the
regulation of NSC apoptosis (Fig. 9g).
Finally, media generated after irradiation of neuro-
spheres at 10 Gy substantially suppressed neuronal differ-
entiation of NCS (Fig. 9h, i), reminiscent of the effects of
media transfer experiments using non-stem U87MG glio-
blastoma cells with high radiation-induced secretion of IL8
and TGFb. It should be highlighted the absence of negative
effects for the control NSC by pretreatment with fresh
serum-free culture medium, compared to small negative
effects of the fresh GB media pretreatment described above
(see Fig. 5f). It makes the media transfer experiments from
irradiated neurospheres to non-targeted bystander NSC
very convincing.
Discussion
One of the primary goals in radiation therapy is to enhance
the efficiency of tumor cell killing without seriously
hampering the functional integrity of normal differentiated
cells and multipotent adult stem cells in the tissue micro-
environment. However, demonstration of bystander effects
in non-targeted cells in diverse human cell systems raises a
serious health concern [18, 32]. Understanding the intrinsic
cellular communication between cancer and non-cancer
cells, especially after radiation exposure, is highly desir-
able for development of strategies to either minimize or
prevent the harmful radiation effects on normal stem cells,
which are critical for tissue homeostasis. In this study, we
explored the concept that the cellular signaling trigged by
radiation exposure in cancer cells can produce adverse
effects on the integrity and function of adult stem cells.
The results of our study demonstrated the existence of
intercellular crosstalk of glioblasoma (GB) cells, as well as
a subpopulation of glioma stem-like cells (GSC), with NSC
before and after ionizing irradiation. Although, we
observed a qualitative similarity in the bystander effects of
non-stem GB cells and GSC on the naive NSC via soluble
factors, further investigation might reveal quantitative
differences in the extent of bystander effects. For example,
the well pronounced pro-apoptotic features of irradiation
for GSC in our study (that was mediated, at least partially,
via endogenous expression of both FasL and Fas) were in
contrast to non-apoptotic mechanism of radiation-induced
death for non-stem U87MG glioblastoma cells. Distinct
mechanisms for radiation-induced non-apoptotic death of
non-stem glioblastoma cells and for Fas-L/Fas-mediated
apoptosis of these cells were previously described [33].
Interestingly, there are contradictory observations regard-
ing the radioresistance of GSC. McCord et al. described
establishing several GSC lines that were substantially more
radiosensitive than the corresponding parent GB lines [34].
In contrast, other investigators observed a pronounced
increase in the subpopulation of CD133? glioblastoma
stem-like cells after irradiation due to preferential activa-
tion of the DNA damage response [35]. It is still unclear
whether this is due to selective expansion of CD133? cells,
or it is simply due to dedifferentiation of differentiated
cancer cells. Mechanisms of dedifferentiation of cancer
cells, including glioblastoma cells, are under active
investigation.
An exciting recent publication identified a core set of
neurodevelopmental transcription factors (SOX2, POU3F2,
SALL2 and OLIG2) that were sufficient to fully reprogram
differentiated GB cells to glioblastoma stem-like cells with
recapitulating phenotype of native GSC. OLIG2-dependent
LSD1 (Lysine-specific demethylase-1, one of the compo-
nents of a chromatin-modifying complex) was necessary
for GSC survival; treatment with a specific LSD1 inhibitor
reduced cells survival [36]. It was supposed in this that
inhibition of LSD1 had potential therapeutic significance.
However, the well-known role of LSD1 in the positive
control of human NSC proliferation [37] challenges this
suggestion.
The ideal mechanism for killing cancer cells via death
receptor-mediated apoptosis appeared to be rarely func-
tional if ionizing irradiation was used alone. The most
probable scenarios for cancer cells exposed to low linear
energy transfer (LET) irradiation are: (i) undergo cell
senescence (a permanent proliferative arrest) with the
subsequent slow death due to changing balance between of
autophagy and necrosis; (ii) activate the intrinsic mito-
chondria-mediated death pathways using ROS-induced
DNA-damage response when these pathways were main-
tained in cancer cells [38, 39]. As a rule, the second sce-
nario might require an additional suppression of cell
survival pathways that are over-activated in cancer cells,
for example, PI3K-AKT, as we observed in the current
study, or TGFb [22] and STAT3 [30, 40]. GSC also con-
tained constitutive NF-jB and STAT3 activities [41] and
could be radio-synthesized by the corresponding small
molecule inhibitors. An additional opportunity for inhibi-
tion of glioblastoma proliferation is linked with high levels
of expression of PKC-iota in these cancer cells. ICA-1, a
specific inhibitor of PKC-iota, alone or especially in
combination with TRAIL suppressed proliferation and
induced apoptosis in glioblastoma lines [42, 43].
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At present, due to significant technological advances,
ionizing radiation can very selectively target the tumors
with limited side effects for normal tissues. The existence
of intercellular communication between targeted cancer
cells and bystander (non-irradiated) normal cells, however,
could dramatically affect the fate of the bystander normal
cells [18]. For cranial irradiation of brain tumor, NSC
could be in many cases a critical bystander target [6, 10].
Our previous study demonstrated that radiation-induced
apoptosis of NSC in cell culture is mediated by TRAIL/
TRAIL-R2 interaction through autocrine or paracrine
stimulation. It created mechanisms for killing of both
directly irradiated NSC and bystander NSC. This finding
was in contrast to the popular belief that TRAIL-dependent
signaling mechanism preferentially killed cancer cells.
Furthermore, ionizing irradiation of cancer cells, such as
neuroblastoma [12] or glioblastoma (the current study),
was accompanied by increased production and secretion of
TRAIL and FasL resulting in upregulation of apoptosis of
bystander NSC/NPC, while malignant cancer cells exhib-
ited a substantial anti-apoptotic protective mechanisms.
Indeed, massive productions of pro-inflammatory cytokines
after irradiation of glioblastoma plays pronounced anti-
apoptotic role for cancer cells. Furthermore, in certain
circumstances, this cytokine secretion could increase the
survival of bystander NSC/NPC, but with simultaneous
inhibition of the neuronal pathway of differentiation.
Interestingly, there was a strong asymmetry in bystander
response of differentiating astrocyte precursors compared
to differentiating neuronal precursors, since the media from
irradiated glioblastoma cultures had favorable effects for
astrocyte differentiation. To our best knowledge, inhibition
of the neuronal pathway of NSC differentiation by factors
that were produced by directly irradiated glioblastoma cells
is a new finding, while positive effects of c-irradiation on
the astrocyte differentiation via up-regulation of IL6-
STAT3 have been recently described [44].
The high basal levels of IL6, IL8 and COX2-driven
production of PGE2 in glioblastoma cells are direct
downstream targets of the constitutive IKK-NF-jB activ-
ity. On the other hand, COX2-dependent product PGE2
with numerous signaling functions actually could suppress
the late NF-jB activation to establish the feedback mech-
anism allowing for restriction of COX2 induction and
PGE2 secretion [45]. This may be a reason for a dose-
dependent decrease of the high basal NF-jB phospo-p65
and COX2 activity 3-6 h after irradiation of glioblastoma
cells (see Figs. 1c, d).
A strong dependence of glioblastoma cell survival on
activation of two major signaling pathways IKK-NF-jB and
PI3K-AKT, was further confirmed in our study by the syn-
ergistic induction of apoptosis of U87MG cells using com-
bined treatment with small molecule inhibitors of both
pathways (see Fig. 2b). Paradoxically, BMS345541, an
IKK-NF-jB inhibitor, alone or in combination with c-irra-
diation mainly induced non-apoptotic death of glioblastoma
cells. An additional example of induction of death of glio-
blastoma cells via senescence and the subsequent necrosis
was a combination of ATM-kinase inhibitor KU55933 and
ionizing irradiation (see Fig. 2c). Since STAT3 activation
and translocation is one of the critical downstream targets of
ATM-kinase [46], suppression of STAT3 translocations by a
specific small molecule inhibitor STX-0119 in concert with
irradiation also resulted in G2/M arrest, senescence and slow
cell death (see Fig. 2d). In a recent publication, the usage of
Vacquinol-1, a MKK4-JNK inhibitor, had dramatic effects
for cell physiology of GB in culture conditions and in vivo
due to the induction of rapid endocytic-like activity followed
by disruption of the cell membrane and cell death [47]. On
the other hand, interferon-b via massive alteration in
expression of its target genes could overcome therapy
resistance (including irradiation) in GSC [48].
Radiation-induced up-regulation of cytokine and death
ligand secretion by glioblastoma cells established the
conditions for radiation-induced bystander response of
NSC that was mediated mostly soluble factors released in
the media by cancer cells. The characteristic feature of
apoptosis in the bystander NSC was its suppression by anti-
TRAIL antibody. Human NSC were also sensitive to Fas-
Ligand- and to TNFa-induced cell death, due to the pre-
sence of the corresponding receptors. TNFa could be
produced in vivo by microglial cells of the brain [49],
targeting via TNFR1 both apoptotic and necrotic pathways
in NSC. On the other hand, beside induction of cell death,
TNFa may serve as a classical inducer of cell survival
pathways via NF-jB activation. Dual functions of TNFa
highlight its central role in balancing between life and
death during different types of stress responses [50–52].
In general, the irradiation of cells targets numerous cell
signaling pathways and induces changes in expression of
several hundred genes [53]. However, radiation-induced
gene activation shares some common features with other
types of cell stress, including modulation of the pro-
inflammatory and anti-inflammatory gene expression of
specific sets of cytokines and their receptors, COX2
expression and COX2-directed production of PGE2,
expression of death ligands and death receptors [18, 54].
Paradoxically, non-active COX2 was located in the nuclei,
while it was translocated to the cytoplasm upon activation
[55]; (see also Fig. 1b). Production and secretion of cyto-
kines and PGE2 after irradiation may serve as a basis for
the induction of propagating the bystander response of non-
targeted cells. Bystander suppression of neuronal differ-
entiation was especially strong in the case of radiation-
induced intercellular crosstalk between irradiated cancer
(neuroblastoma or glioblastoma) cells and NSC.
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Taken together, results of our study indicated that
intercellular communication between glioblastoma cells
and bystander NSC/NPC could be involved in the ampli-
fication of cancer pathology in the brain. We expect that
further investigations of the mechanisms of radiation-
induced neurotoxicity at the level of NSCs may open new
opportunities to protect and maintain neurogenesis after




Fibronectin, laminin and polyornithine were obtained from
Sigma-Aldrich (St. Louis, MO, USA). PI3 K inhibitor
LY294002, IKK inhibitor BMS345541, STAT3 inhibitor-6
S3I-201 (also known as NSC 74859), MEK inhibitor
U0126, MAPK p38 inhibitor SB203580 and JNK inhibitor
SP600125 were purchased from Calbiochem (La Jolla, CA,
USA). Human soluble Killer-TRAIL (recombinant), Fas-
Ligand (recombinant), anti-human TRAIL and anti-human
Fas-Ligand antibodies were purchased from Alexis (San
Diego, CA, USA); human TNFa, TGFb1, IL6 and IL8
were obtained from R&D Systems (Minneapolis, MN,
USA).
Human embryonic neural stem cells (NSC) in culture
Cryopreserved human embryonic neural stem cells (NSC)
were obtained from Gibco/Life Technologies (Carlsbad,
CA, USA) as a commercially available product (N7800-
200). The cells were derived from NIH approved H9
(WA09) human embryonic stem cells. The cells were
plated in 6-well culture plates coated with fibronectin and
incubated at 37 "C in complete growth medium NSC/SFM,
which contained serum-free DMEM/F12 supplemented
with 2 mM GlutaMAX, bFGF (20 ng/ml), EGF (20 ng/ml)
and StemPRO neural supplement (2 %). All reagents were
obtained from from Gibco/Life Technologies (Carlsbad,
CA, USA).
Neuronal differentiation of NSCs in culture
Neural stem cells were plated on polyornithine- and lami-
nin-coated 6-well plates, which contained similarly coated
cover slips, in complete NSC/SFM. After 2 days, neuronal
differentiation was initiated by neuronal differentiation
media, which contains Neurobasal medium, B-27 Serum-
free supplement (2 %) and 2 mM GlutaMAX (Gibco/Life
Technologies). Medium was changed every 2 days. A
neuronal phenotype was confirmed using immunofluores-
cence detection 10 days after initiation of differentiation.
Glial (astrocyte) differentiation of NSCs in culture
Neural stem cells were plated on polyornithine- and lami-
nin-coated 6-well plates, which contained similarly coated
cover slips, in complete NSC/SFM. After 2 days, astro-
cytes differentiation was initiated by astrocyte differentia-
tion media, which contains DMEM, N-2 supplement (1 %),
1 % FBS and 2 mM GlutaMAX (Gibco/Life Technolo-
gies). Medium was changed every 2 days. An astrocyte
phenotype was confirmed using immunofluorescence
detection of GFAP 10–18 days after initiation of
differentiation.
U87MG glioblastoma cells
Human glioblastoma (U87MG or HTB-14, ATCC) cell line
was obtained from ATCC (Manassas, VA, USA). Cells
were cultured in DMEM supplemented with 10 % FBS and
1 % pyruvate. For neurosphere formation, U87MG glio-
blastoma cells were cultured in the serum-free media
DMEM/F12 supplemented with 2 mM GlutaMAX, bFGF
(20 ng/ml), EGF (20 ng/ml) and B27 supplement (2 %).
All reagents were obtained from from Gibco/Life Tech-
nologies (Carlsbad, CA, USA). After 15–20 passages,
spheroid U87MG culture was significantly enriched by
CD133? cells. For radiation treatment and immunocyto-
chemical analysis U87MG spheroids were attached to
fibronectin matrix.
Immunocytochemistry analysis
Cells were fixed with 4 % paraformaldehyde in PBS for
60 min. Immunochemical staining was performed using
standard protocols. Cells were stained for the undifferen-
tiated NSC marker, Nestin (using mAb from Millipore,
Temecula, CA, USA) and for the neuronal marker, Dou-
blecortin using Ab from Cell Signaling, (Danvers, MA,
USA). Additional markers include SOX2, GFAP, CD133
and COX2 (using Abs from Cell Signaling). The secondary
Abs were Alexa Fluor 594 goat anti-mouse IgG and Alexa
Fluor 488 goat anti-rabbit IgG from Molecular Probes/Life
Technologies (Carlsbad, CA, USA). A laser scanning
confocal microscope (Nikon TE 2000 with EZ-C1 soft-
ware, Tokyo, Japan) was used for immunofluorescence
image analysis.
Irradiation procedures
To determine sensitivity to c-rays, plated NSC, astrocytes
and glioblastoma cells were exposed to radiation from a
Apoptosis (2014) 19:1736–1754 1751
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Gammacell 40 137Cs irradiator (dose rate, 0.82 Gy/min) at
Columbia University. Six to 48 h after irradiation, cells
were stained with PI and analyzed by flow cytometry for
cell cycle-apoptosis studies.
FACS analysis of TRAIL, TRAIL-R2/DR5, TRAIL-
R1/DR4, FAS, FAS-L and CD133 levels
Surface levels of TRAIL, TRAIL-R2/DR5, TRAIL-R1/
DR4, FAS, FAS-L and CD133 on human cell lines were
determined by staining with a PE-conjugated Abs to the
corresponding human proteins (R&D System, Minneapolis,
MN, USA and eBioscience, San Diego, CA, USA) and
subsequent flow cytometry. For detection of total levels of
antigen proteins, cells were fixed and permeabilized using
0.5 % Triton X-100 in PBS. PE-conjugated nonspecific
mouse IgG1 was used as an immunoglobulin isotype
control. A FACS Calibur flow cytometer (Becton–Dickin-
son, Mountain View, CA, USA) and the CellQuest program
were used to perform flow cytometric analysis. All exper-
iments were independently repeated 3-5 times.
Cell death studies
For induction of apoptosis, cells were exposed to c-irra-
diation (2–10 Gy) alone or in the presence of small mol-
ecule inhibitors of cell signaling pathways. Furthermore,
apoptosis was induced TRAIL, TNFa, FasL, TGFb and
CHX alone or in combination. Media transfer experiments
from conditioned and irradiated U87MG cells to naı¨ve
NSC were also used for induction of NSC apoptosis.
Apoptosis levels were then assessed by propidium iodide
(PI) staining and quantifying the percentage of hypodiploid
nuclei (pre-G1) using FACS analysis or by quantifying the
percentage of Annexin-V-FITC-positive cells (BD
Pharmingen, San Diego, CA) that was performed on a
FACS Calibur flow cytometer (Becton–Dickinson) using
the CellQuest program. Trypan blue exclusion test was
used for determination of cell viability and total death
levels. Clonogenic survival assay of U87MG cells before
and after treatment with increased doses of c-radiation in
the presence or absence of a PI3K-AKT inhibitor
LY294002 (40 lM), an IKK-NF-jB inhibitor BMS345541
(10 lM) or several other small molecule inhibitors was
also performed using a standard method.
Western blot analysis
Total cell lysates (50 lg protein) were resolved on SDS-
PAGE, and processed according to standard protocols. The
monoclonal antibodies used for Western blotting included:
anti-b-Actin (Sigma, St. Louis, MO, USA); anti-caspase-3
(Cell Signaling, Danvers, MA, USA); The polyclonal
antibodies used included anti-phospho-p44/p42 MAP
kinase (T202/Y204) and anti-p44/p42 MAP kinase; anti-
phospho-JNK and anti-JNK1-3; anti-phospho-AKT (S473)
and anti-AKT; anti-phospho-p65 (S536) NF-jB and anti-
p65 NF-jB, anti-phospho-STAT3 (Y705) and anti-STAT3;
anti-p53, anti-BAX, anti-SOX2, anti-TGF-b1, anti-TGF-b-
Receptor-2 and anti-PARP-1 (Cell Signaling, Danvers,
MA, USA); anti-FAS, anti-FAS-Ligand, anti-DR5/TRAIL-
R2, anti-DR4/TRAIL-R1 and anti-TRAIL (Alexis, San
Diego, CA, USA); anti-SURVIVIN (R&D, USA) The
secondary antibodies were conjugated to horseradish per-
oxidase; signals were detected using the ECL system
(Thermo Scientific, Rockford, IL, USA).
ELISA for IL6, IL8, TGFb1 and TRAIL detection
in the media
The ELISA kits for detection of human cytokines were
from R&D System, Minneapolis, MN, USA and eBio-
science, San Diego, CA, USA.
Statistical analysis
Data from four to five independent experiments were cal-
culated as means and standard deviations. Comparisons of
results between treated and control groups were made by
the Students’ t tests. A p value of 0.05 or less between
groups was considered significant.
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